These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9839011

  • 1. Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase.
    Lee YS, Chen Z, Kador PF.
    Bioorg Med Chem; 1998 Oct; 6(10):1811-9. PubMed ID: 9839011
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors.
    El-Kabbani O, Darmanin C, Schneider TR, Hazemann I, Ruiz F, Oka M, Joachimiak A, Schulze-Briese C, Tomizaki T, Mitschler A, Podjarny A.
    Proteins; 2004 Jun 01; 55(4):805-13. PubMed ID: 15146479
    [Abstract] [Full Text] [Related]

  • 4. Isolation of a non-covalent aldose reductase-nucleotide-inhibitor complex.
    Sugiyama K, Chen Z, Lee YS, Kador PF.
    Biochem Pharmacol; 2000 Feb 15; 59(4):329-36. PubMed ID: 10644040
    [Abstract] [Full Text] [Related]

  • 5. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
    Kucerova-Chlupacova M, Halakova D, Majekova M, Treml J, Stefek M, Soltesova Prnova M.
    Chem Biol Interact; 2020 Dec 01; 332():109286. PubMed ID: 33038328
    [Abstract] [Full Text] [Related]

  • 6. Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.
    El-Kabbani O, Ramsland P, Darmanin C, Chung RP, Podjarny A.
    Proteins; 2003 Feb 01; 50(2):230-8. PubMed ID: 12486717
    [Abstract] [Full Text] [Related]

  • 7. Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study.
    El-Sayed S, Metwally K, El-Shanawani AA, Abdel-Aziz LM, El-Rashedy AA, Soliman MES, Quattrini L, Coviello V, la Motta C.
    Bioorg Med Chem Lett; 2017 Oct 15; 27(20):4760-4764. PubMed ID: 28935265
    [Abstract] [Full Text] [Related]

  • 8. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
    Celestina SK, Sundaram K, Ravi S.
    Bioorg Chem; 2020 Apr 15; 97():103640. PubMed ID: 32086051
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: stereospecific interaction between the enzyme and a cyclic imide type inhibitor.
    El-Kabbani O, Darmanin C, Oka M, Schulze-Briese C, Tomizaki T, Hazemann I, Mitschler A, Podjarny A.
    J Med Chem; 2004 Aug 26; 47(18):4530-7. PubMed ID: 15317464
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phenolic marine natural products as aldose reductase inhibitors.
    Manzanaro S, Salva J, de la Fuente JA.
    J Nat Prod; 2006 Oct 26; 69(10):1485-7. PubMed ID: 17067167
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2', 5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide (Fidarestat): its absolute configuration and interactions with the aldose reductase by X-ray crystallography.
    Oka M, Matsumoto Y, Sugiyama S, Tsuruta N, Matsushima M.
    J Med Chem; 2000 Jun 15; 43(12):2479-83. PubMed ID: 10882376
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of human aldehyde reductase: characterization of the active site pocket.
    Barski OA, Gabbay KH, Grimshaw CE, Bohren KM.
    Biochemistry; 1995 Sep 05; 34(35):11264-75. PubMed ID: 7669785
    [Abstract] [Full Text] [Related]

  • 18. 3D-pharmacophore analyses of aldose reductase inhibitory spiroquinazolinones.
    Nakao K, Asao M, Shirai H, Shimizu R.
    Drug Des Discov; 1999 Aug 05; 16(2):155-63. PubMed ID: 10533811
    [Abstract] [Full Text] [Related]

  • 19. Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors.
    Jung HA, Moon HE, Oh SH, Kim BW, Sohn HS, Choi JS.
    Chem Biol Interact; 2012 May 30; 197(2-3):110-8. PubMed ID: 22543015
    [Abstract] [Full Text] [Related]

  • 20. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T, Petrash JM.
    Biochemistry; 1996 Aug 27; 35(34):11196-202. PubMed ID: 8780524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.